<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font26 { font-size : 26; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font28 { font-size : 28; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font28">the </span>
   <span class="font26">with </span>
   <span class="font18">patients </span>
   <span class="font17">for </span>
   <span class="font16">risk </span>
   <span class="font15">COVID- </span>
   <span class="font14">data </span>
   <span class="font14">are </span>
   <span class="font14">infection </span>
   <span class="font13">from </span>
   <span class="font13">{background </span>
   <span class="font13">systemic </span>
   <span class="font12">disease </span>
   <span class="font12">safety </span>
   <span class="font12">use </span>
   <span class="font12">increased </span>
   <span class="font12">infections </span>
   <span class="font12">potential </span>
   <span class="font12">margin </span>
   <span class="font12">clinical </span>
   <span class="font12">coronavirus </span>
   <span class="font12">respiratory </span>
   <span class="font12">that </span>
   <span class="font12">{border-style </span>
   <span class="font12">therapy </span>
   <span class="font12">px;} </span>
   <span class="font12">rheumatoid </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">treatment </span>
   <span class="font11">immunosuppressive </span>
   <span class="font11">not </span>
   <span class="font11">The </span>
   <span class="font11">compared </span>
   <span class="font11">serious </span>
   <span class="font11">associated </span>
   <span class="font11">rates </span>
   <span class="font11">viral </span>
   <span class="font11">CI, </span>
   <span class="font11">suggest </span>
   <span class="font11">were </span>
   <span class="font11">arthritis </span>
   <span class="font11">immune-mediated </span>
   <span class="font11">rituximab </span>
   <span class="font11">trials </span>
   <span class="font11">acute </span>
   <span class="font11">etÂ </span>
   <span class="font11">has </span>
   <span class="font11">have </span>
   <span class="font11">severe </span>
   <span class="font11">syndrome </span>
   <span class="font11">trial </span>
   <span class="font11">COVID-. </span>
   <span class="font11">Table </span>
   <span class="font11">agents </span>
   <span class="font11">available </span>
   <span class="font11">found </span>
   <span class="font11">had </span>
   <span class="font11">may </span>
   <span class="font11">results </span>
   <span class="font11">(.) </span>
   <span class="font11">.-.). </span>
   <span class="font11">Conclusions </span>
   <span class="font11">been </span>
   <span class="font11">harm </span>
   <span class="font11">immunomodulatory </span>
   <span class="font11">inflammatory </span>
   <span class="font11">inhibitors </span>
   <span class="font11">methotrexate </span>
   <span class="font11">psoriasis </span>
   <span class="font10">(eg, </span>
   <span class="font10">SARS-CoV- </span>
   <span class="font10">but </span>
   <span class="font10">corticosteroids </span>
   <span class="font10">during </span>
   <span class="font10">infection. </span>
   <span class="font10">outcomes </span>
   <span class="font10">overall </span>
   <span class="font10">px; </span>
   <span class="font10">studies </span>
   <span class="font10">study </span>
   <span class="font10">such </span>
   <span class="font10">was </span>
   <span class="font10">{font-family </span>
   <span class="font10">Acad </span>
   <span class="font10">TNF </span>
   <span class="font10">[e-pub </span>
   <span class="font10">active </span>
   <span class="font10">ahead </span>
   <span class="font10">antiviral </span>
   <span class="font10">based </span>
   <span class="font10">biologic </span>
   <span class="font10">complications </span>
   <span class="font10">critically </span>
   <span class="font10">doses </span>
   <span class="font10">drugs </span>
   <span class="font10">efficacy </span>
   <span class="font10">font-size </span>
   <span class="font10">hydroxychloroquine </span>
   <span class="font10">ill </span>
   <span class="font10">immunosuppression </span>
   <span class="font10">including </span>
   <span class="font10">increase </span>
   <span class="font10">influenza </span>
   <span class="font10">large </span>
   <span class="font10">low </span>
   <span class="font10">poor </span>
   <span class="font10">this </span>
   <span class="font10">zoster </span>
   <span class="font10">&amp;lt;Â </span>
   <span class="font10">(COVID-) </span>
   <span class="font10">Care </span>
   <span class="font10">Data </span>
   <span class="font10">Dermatol </span>
   <span class="font10">Dis </span>
   <span class="font10">Infect </span>
   <span class="font10">JAK </span>
   <span class="font10">Med </span>
   <span class="font10">Rheum </span>
   <span class="font10">Rheumatol </span>
   <span class="font10">URIs </span>
   <span class="font10">any </span>
   <span class="font10">autoimmune </span>
   <span class="font10">benefit </span>
   <span class="font10">controlled </span>
   <span class="font10">double; </span>
   <span class="font10">evidence </span>
   <span class="font10">factor </span>
   <span class="font10">hospitalized </span>
   <span class="font10">infectious </span>
   <span class="font10">lupus </span>
   <span class="font10">mycophenolate </span>
   <span class="font10">necrosis </span>
   <span class="font10">noted </span>
   <span class="font10">patient </span>
   <span class="font10">patients. </span>
   <span class="font10">possible, </span>
   <span class="font10">prednisone </span>
   <span class="font10">randomized </span>
   <span class="font10">requiring </span>
   <span class="font10">should </span>
   <span class="font10">these </span>
   <span class="font10">treated </span>
   <span class="font10">used </span>
   <span class="font10">when </span>
   <span class="font10">.The </span>
   <span class="font10">COVID-, </span>
   <span class="font10">East </span>
   <span class="font10">Patients </span>
   <span class="font10">Res </span>
   <span class="font10">after </span>
   <span class="font10">also </span>
   <span class="font10">antimalarials </span>
   <span class="font10">article </span>
   <span class="font10">atopic </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">both </span>
   <span class="font10">bowel </span>
   <span class="font10">cases </span>
   <span class="font10">context </span>
   <span class="font10">corticosteroid </span>
   <span class="font10">daily </span>
   <span class="font10">dermatologic </span>
   <span class="font10">drug </span>
   <span class="font10">dupilumab </span>
   <span class="font10">effect </span>
   <span class="font10">higher </span>
   <span class="font10">limited </span>
   <span class="font10">literature </span>
   <span class="font10">mortality </span>
   <span class="font10">needed </span>
   <span class="font10">other </span>
   <span class="font10">pandemic. </span>
   <span class="font10">psoriatic </span>
   <span class="font10">rate </span>
   <span class="font10">recent </span>
   <span class="font10">recommendations </span>
   <span class="font10">regarding </span>
   <span class="font10">registry </span>
   <span class="font10">reported </span>
   <span class="font10">significant </span>
   <span class="font10">similar </span>
   <span class="font10">solid; </span>
   <span class="font10">systematic </span>
   <span class="font10">their </span>
   <span class="font10">tumor </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(adjusted </span>
   <span class="font10">Although </span>
   <span class="font10">COVID-: </span>
   <span class="font10">Elsevier </span>
   <span class="font10">Further </span>
   <span class="font10">However, </span>
   <span class="font10">III </span>
   <span class="font10">IL- </span>
   <span class="font10">Janus </span>
   <span class="font10">Middle </span>
   <span class="font10">Similarly, </span>
   <span class="font10">Therapeutic </span>
   <span class="font10">all </span>
   <span class="font10">arthritis: </span>
   <span class="font10">between </span>
   <span class="font10">bold </span>
   <span class="font10">case </span>
   <span class="font10">centre </span>
   <span class="font10">comparable </span>
   <span class="font10">consider </span>
   <span class="font10">courier; </span>
   <span class="font10">cyclosporine </span>
   <span class="font10">effects </span>
   <span class="font10">em; </span>
   <span class="font10">factors </span>
   <span class="font10">herpes </span>
   <span class="font10">hospitalization </span>
   <span class="font10">immunosuppressed </span>
   <span class="font10">incidence </span>
   <span class="font10">inhibition </span>
   <span class="font10">its </span>
   <span class="font10">kinase </span>
   <span class="font10">level </span>
   <span class="font10">management </span>
   <span class="font10">most </span>
   <span class="font10">need </span>
   <span class="font10">observational </span>
   <span class="font10">over </span>
   <span class="font10">pandemic </span>
   <span class="font10">placebo </span>
   <span class="font10">pooled </span>
   <span class="font10">psoriasis: </span>
   <span class="font10">pt;} </span>
   <span class="font10">ratio, </span>
   <span class="font10">relevant </span>
   <span class="font10">research </span>
   <span class="font10">resource </span>
   <span class="font10">responses </span>
   <span class="font10">review </span>
   <span class="font10">series </span>
   <span class="font10">show </span>
   <span class="font10">showed </span>
   <span class="font10">there </span>
   <span class="font10">tofacitinib </span>
   <span class="font10">venous </span>
   <span class="font10">which </span>
   <span class="font10">who </span>
  </p>
 </body>
</html>
